. DouglasWW. Histamine, 5H tryptamine (serotonin) and their antagonists. In: GillmanAGGoodmanCFRailTW, eds. The pharmacologic basis of therapeutics. New York: McMillan Publishing, 1985; 605–38.
2.
. McEvoyGK, ed. American Hospital Formulary Service—Drug Information, 1990. Bethesda: American Society of Hospital Pharmacists, 1990;2–5.
3.
. NormanPS. Modulation of the mast cell and inhibition of its mediators. J Allergy Clin Immunol1985;76:366–8.
4.
. LaduronPMJanssenPFMGommerenWIn vitro and in vivo binding characteristics of a new long-acting histamine H-1 antagonist, astemizole. Mol Pharmacol1982;21:294–300.
5.
. VandenBussche GEmanuelMBRombautN. Clinical profile of astemizole: a survey of 50 double-blind trials. Ann Allergy1987;58:184–8.
6.
. VandenBussche GRombautNSchuermansVClinical activity of astemizole: a review of world-wide data. In: PharmaceuticaJanssen, ed. Astemizole: a new, non-sedative, long-acting H-l antagonist. Oxford: Medicine Publishing Foundation, 1983; 101–12.
